Literature DB >> 7939145

Influence of degradable starch microspheres on the human nasal mucosa.

K Holmberg1, E Björk, B Bake, P Edman.   

Abstract

The effect of the nasal administration of degradable starch microspheres (DSM) on the mucociliary system and the geometry of the nasal cavities were evaluated in 15 healthy volunteers. The baseline values for mucociliary clearance of the right nasal cavity were determined on two separate days for each subject using the saccharin-dyes test. Acoustic rhinometry was performed before and during the saccharin-dyes test. The patients then started the treatment period and inhaled 10 mg of DSM intranasally once daily in each nostril for 8 days. The saccharin-dyes test was performed 5 min after the deposition of the DSM on day 1 and day 8. The geometry of the nasal cavities was determined before, 7 min after deposition, and after the end of the saccharin test. Both tests were also performed two days after the end of the treatment period. Each subject was examined by means of rhinoscopy on every visit during the investigation. No changes in mucociliary clearance or in the geometry of the nasal cavities were found after repeated administration of starch microspheres. Thus, intranasally-administered degradable starch microspheres did not have an adverse effect on human nasal mucociliary clearance, and the DSM did not cause any congestion or decongestion of the mucosa.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7939145

Source DB:  PubMed          Journal:  Rhinology        ISSN: 0300-0729            Impact factor:   3.681


  4 in total

1.  A novel method for the preparation of biodegradable microspheres for protein drug delivery.

Authors:  R Pareta; M J Edirisinghe
Journal:  J R Soc Interface       Date:  2006-08-22       Impact factor: 4.118

2.  Starch-based microspheres produced by emulsion crosslinking with a potential media dependent responsive behavior to be used as drug delivery carriers.

Authors:  Patrícia B Malafaya; Frank Stappers; Rui L Reis
Journal:  J Mater Sci Mater Med       Date:  2006-04       Impact factor: 3.896

3.  In vitro tolerability of human nasal mucosa: histopathological and scanning electron-microscopic evaluation of nasal forms containing Sandostatin.

Authors:  A de Fraissinette; M Kolopp; I Schiller; G Fricker; C Gammert; A Pospischil; J Vonderscher; F Richter
Journal:  Cell Biol Toxicol       Date:  1995-10       Impact factor: 6.691

Review 4.  Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage.

Authors:  Amy Corbin Farr; May P Xiong
Journal:  Mol Pharm       Date:  2020-10-09       Impact factor: 4.939

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.